Moneyview IPO Day 2: GMP ₹0
Alright folks, let’s dive into the second day of the Moneyview IPO’s subscription period. As of the end of Day 2, we’re seeing a complete lull across all investor categories. It’s a bit of a quiet market out there for Moneyview right now, with zero subscriptions reported for Retail, NII, and QIB investors. This means the total subscription stands at a flat 0x. Let’s break down what this really means for potential investors.
Subscription Status
Observing the subscription numbers, or rather the lack thereof, is quite telling. On Day 2, we’ve seen absolutely no traction in any segment. The Retail Investor portion, which usually sees a good chunk of interest, is at 0x. Similarly, the Non-Institutional Investor (NII) category, typically for high net-worth individuals, is also at 0x. Even the Qualified Institutional Buyer (QIB) segment, often a leading indicator of institutional confidence, is showing zero subscriptions. This is unusual, especially by the end of the second day of a Mainboard IPO. Typically, you’d expect at least some initial interest to build momentum. The absence of any bids could mean a few things: investors might be waiting for more clarity, perhaps observing the market sentiment, or they might be reserving their decision for the final day. It’s certainly something to keep an eye on as the IPO progresses through its remaining days.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 20.41x | |
| NII / HNI | 120.37x | |
| QIB | 230.54x | |
| Total | 230.54x |
GMP Update
Now, let’s talk Grey Market Premium (GMP). Today, the GMP for Moneyview IPO is at ₹0. This is unchanged from yesterday’s reported GMP of ₹0. A GMP of ₹0 suggests that the market is currently not pricing in any premium over the issue price of ₹34. The expected listing price is also hovering around the issue price of ₹34. This lack of positive or negative indication from the grey market can be interpreted in a couple of ways. On one hand, it means there’s no immediate fear of a discount listing. On the other hand, it also indicates a lack of strong demand or positive sentiment that would drive the GMP upwards. The fact that it has remained stagnant at ₹0 is notable and aligns with the subdued subscription numbers we’re seeing.
Should You Apply?
So, the big question: should you put your money into the Moneyview IPO at this stage? Based on the current data, it’s a tricky call. The subscription numbers are exceptionally low, and the GMP is at zero, indicating a neutral market sentiment right now. This could be an opportunity for astute investors who believe in the company’s fundamentals and are looking for an entry point before potential last-minute surges. However, it also carries a risk. The lack of immediate interest might be a signal that the market isn’t overly excited about this offering, or perhaps investors are waiting for the final day’s subscription figures. Remember, the IPO period is from September 24, 2026, to September 28, 2026, so there’s still time. The lot size is 441 shares, and the issue price is ₹34. It’s always a good idea to do your own thorough research into Moneyview’s business model, financial health, and future prospects. As per SEBI advisor guidelines, informed decisions are crucial. You can View Full Moneyview IPO Details for more in-depth analysis.